Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Iridex Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 28 | 31 | +3 |
| Shares | 3.89M | 3.55M | −332.9K (−8.6%) |
| Value | $8.43M | $9.03M | +$598.4K (+7.1%) |
New holders (5)
Institutions that held Iridex Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARS Investment Partners, LLC | 71,492 | $181.6K | 0.02% |
| Susquehanna International Group, LLP | 52,135 | $132.4K | 0.00% |
| Wolverine Trading, LLC | 31,039 | $78.8K | 0.00% |
| Citigroup Inc | 5,668 | $14.4K | 0.00% |
| JPMorgan Chase & Co | 15 | $38 | 0.00% |
Sold out (2)
Institutions that held Iridex Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Isthmus Partners, LLC | 391,133 | $848.8K |
| StoneX Group Inc. | 27,160 | $58.9K |